Rabeprazole, clarithromycin, and amoxicillin Helicobacter pylori eradication therapy: Report of an efficacy study

World Journal of Gastroenterology

Volumn 20, Issue 13, 2014, Pages 3615-3619

  Onyekwere, Charles Asabamaka ^a   Odiagah, Joan Nwabuaku ^a   Igetei, Rufina ^a   Emanuel, Amancia Olufunmilayo Duro ^a   Ekere, Francis ^a   Smith, Stella ^b  

^a LAGOS STATE UNIVERSITY TEACHING HOSPITAL   (Nigeria)

^b NIGERIAN INSTITUTE OF MEDICAL RESEARCH   (Nigeria)

Author keywords

Amoxicillin clarithromycin; Eradication therapy; Helicobacter pylori; Rabeprazole triple therapy

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; RABEPRAZOLE; UREA C 13; ANTIINFECTIVE AGENT; ANTIULCER AGENT; UREA;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL CLEARANCE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFECTION CONTROL; MALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UREA BREATH TEST; BREATH ANALYSIS; CHEMISTRY; CONTROLLED STUDY; HELICOBACTER INFECTIONS; MIDDLE AGED; TIME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BREATH TESTS; CLARITHROMYCIN; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; RABEPRAZOLE; TIME FACTORS; TREATMENT OUTCOME; UREA; YOUNG ADULT;

EID: 84897477226     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i13.3615     Document Type: Article

References (21)

1. Marshall BJ. Helicobacter Foundation. Available from: URL: http://www.helico.com viewed 2/12/13
2. Smith SI, Oyedeji KS, Arigbagbu A, Anomneze EE, Chibututu CC, Atimomo EA, Atoyebi A, Adesanya, A, Coker AO. Prevalence of H. pylori in patients with gastritis and peptic ulcer in Western, Nigeria. Biomed Lett 1999; 60: 115-120
3. Jemilohun AC, Otegbayo JA, Ola SO, Oluwasola OA, Akere A. Prevalence of Helicobacter pylori among Nigerian patients with dyspepsia in Ibadan. Pan Afr Med J 2010; 6: 18 [PMID: 21734925]
4. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-781 [PMID: 17170018 DOI: 10.1136/gut.2006.101634]
5. World gastroenterology organization. WGO Practice Guideline: Helicobacter pylori in Developing Countries. Available from: URL: http://www.WGO viewed 09/09/13
6. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut 2012; 61: 646-664 [PMID: 22491499 DOI: 10.1136/gutjnl-2012-302084]
7. Gisbert JP, Pajares JM. Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection--a critical review. Aliment Pharmacol Ther 2004; 20: 1001-1017 [PMID: 15569102]
8. Fallone CA, Barkun AN, Szilagyi A, Herba KM, Sewitch M, Martel M, Fallone SS. Prolonged treatment duration is required for successful Helicobacter pylori eradication with proton pump inhibitor triple therapy in Canada. Can J Gastroenterol 2013; 27: 397-402 [PMID: 23862170]
9. Smith SI, Oyedeji KS, Arigbabu AO, Atimomo C, Coker AO. High amoxycillin resistance in Helicobacter pylori isolated from gastritis and peptic ulcer patients in western Nigeria. J Gastroenterol 2001; 36: 67-68 [PMID: 11211216 DOI: 10.1007/s005350170158]
10. Sandig C, Flechtenmacher C, Stremmel W, Eisenbach C. Pantoprazole induces severe acute hepatitis. Z Gastroenterol 2011; 49: 207-210 [PMID: 21298607 DOI: 10.1055/s-0029-1245613]
11. US dept of Health and Human services. Helicobacter pylori in peptic ulcer disease. NIH consensus statement 1994; 12: 1-23
12. Oztürk E, Yeşilova Z, Ilgan S, Arslan N, Erdil A, Celasun B, Ozgüven M, Daǧalp K, Ovali O, Bayhan H. A new, practical, low-dose 14C-urea breath test for the diagnosis of Helicobacter pylori infection: clinical validation and comparison with the standard method. Eur J Nucl Med Mol Imaging 2003; 30: 1457-1462 [PMID: 14579083 DOI: 10.1007/s00259-003-1244-8]
13. Sokwala A, Shah MV, Devani S, Yonga G. Helicobacter pylori eradication: A randomised comparative trial of 7-day versus 14-day triple therapy. S Afr Med J 2012; 102: 368-371 [PMID: 22668909]
14. Wong BC, Chang FY, Abid S, Abbas Z, Lin BR, Van Rensburg C, Chen PC, Schneider H, Simjee AE, Hamid SS, Seebaran A, Zhang J, Destefano M, Lam SK. Triple therapy with clarithromycin, omeprazole, and amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients in Asia and Africa. Aliment Pharmacol Ther 2000; 14: 1529-1535 [PMID: 11069326]
15. Gisbert JP, Calvet X. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough. Aliment Pharmacol Ther 2011; 34: 1255-1268 [PMID: 22017749 DOI: 10.1111/j.1365-2036.2011.04887.x]
16. Smith Stella. Nigerian Institute of Medical Research. Antibiotic Sensitivity patterns of helicobacter isolates from South West Nigeria. Personal communication
17. Chung JW, Jung YK, Kim YJ, Kwon KA, Kim JH, Lee JJ, Lee SM, Hahm KB, Lee SM, Jeong JY, Yun SC. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial. J Gastroenterol Hepatol 2012; 27: 1675-1680 [PMID: 22849546 DOI: 10.1111/ j.1440-1746.2012.07249.x]
18. Treiber G, Wittig J, Ammon S, Walker S, van Doorn LJ, Klotz U. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study). Arch Intern Med 2002; 162: 153-160 [PMID: 11802748 DOI: 10.1001/archinte.162.2.153]
19. Cai W, Zhou L, Ren W, Deng L, Yu M. Variables influencing outcome of Helicobacter pylori eradication therapy in South China. Helicobacter 2009; 14: 91-96 [PMID: 19751433 DOI: 10.1111/j.1523-5378.2009.00718.x]
20. Georgopoulos SD, Ladas SD, Karatapanis S, Mentis A, Spiliadi C, Artikis V, Raptis SA. Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromycin. Dig Dis Sci 2000; 45: 63-67 [PMID: 10695615]
21. Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007; 102: 1808-1825 [PMID: 17608775]